Jacobio, AstraZeneca ink cancer drug deal
Chinese biotech innovator Jacobio Pharma has struck a global out-licensing deal with pharmaceutical giant AstraZeneca for a promising cancer drug, marking one of the largest cross-border transactions for a Chinese…